SCHEMBL2229276

SCHEMBL2229276

Clc1ccc(Nc2cccc(-c3cnc(-c4ccccc4)o3)n2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.46
TSHR P16473 2/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44
SLC2A1 P11166 1/20 0.40
RAB9A P51151 7/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MITF O75030 1/20 0.40
NPC1 O15118 6/20 0.39
ATM Q13315 1/20 0.39
SMO Q99835 1/20 0.38
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ROCK2 O75116 1/20 0.37
CNR1 P21554 1/20 0.37
SMN1; SMN2 Q16637 5/20 0.36
NFKB1 P19838 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226378 0.86 RAB9A (0.47) KDRTSHRALOX15CASP1SLC2A1
SCHEMBL2226495 0.85 MEN1 (0.39) KDRTSHRSLC2A1RAB9AMEN1
SCHEMBL2226110 0.84 SLC2A1 (0.44) KDRTSHRSLC2A1RAB9AMEN1
SCHEMBL2280201 0.81 FYN (0.39) KDRSLC2A1RAB9AMEN1KMT2A
SCHEMBL2224056 0.77 KARS1 (0.61) KDRTSHRALOX15CASP1RAB9A
SCHEMBL2363523 0.77 KARS1 (0.44) KDRTSHRALOX15CASP1RAB9A
SCHEMBL2352796 0.76 GRM5 (0.41) KDRSLC2A1RAB9AMEN1KMT2A
SCHEMBL4898748 0.75 SLC2A1 (0.50) KDRTSHRSLC2A1RAB9AMEN1
SCHEMBL2227324 0.74 KDR (0.46) KDRTSHRALOX15CASP1SLC2A1
SCHEMBL14673765 0.73 ABL1 (0.39) CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523952-B1 OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2015-03-04 EP claimed
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US claimed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US claimed
CN-102812022-A Thiazole and oxazole kinase inhibitors AB SCIENCE 2012-12-05 CN claimed
EP-2523952-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB Science (FR) 2012-11-21 EP claimed
WO-2011086085-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2011-07-21 WO claimed
EP-2523952-B1 OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2015-03-04 EP disclosed
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US disclosed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US disclosed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US disclosed
CN-102812022-A Thiazole and oxazole kinase inhibitors AB SCIENCE 2012-12-05 CN disclosed
EP-2523952-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB Science (FR) 2012-11-21 EP disclosed
WO-2011086085-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2011-07-21 WO disclosed
WO-2011086085-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2011-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS SYK, LTK, MERTK KDR 79/4885TSHR 1291/4885ALOX15 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.